FDA Commissioner Scott Gottlieb’s Keynote Among Highly Anticipated Sessions at RAPS Regulatory Convergence

Rockville, MD, USA, Aug. 10, 2017 -- The Regulatory Affairs Professionals Society (RAPS) will host its annual Regulatory Convergence conference at the Gaylord National Resort and Convention Center at National Harbor on the DC waterfront 9–12 September. This year’s event features more than 75 educational sessions and over 200 speakers, including an opening keynote from FDA Commissioner Scott Gottlieb, MD. The Convergence is expected to draw more than 2,000 participants. It is the largest annual gathering of the global healthcare regulatory profession. Visit http://raps.org/convergence2017/ for more information.

“This is the premier event dedicated completely to the regulatory profession,” said RAPS Executive Director Paul Brooks. “This is where top regulatory officials, senior executives, innovators and thought leaders come together to share knowledge, get updates, discuss trends and examine regulatory issues in depth from multiple angles.”

Highly anticipated topics on the agenda this year include Europe’s new medical device and in vitro diagnostics regulations, the impact of FDA user fee reauthorizations and the 21^st Century Cures Act, medical device cybersecurity, developments in off-label promotion, regulatory challenges of conducting clinical trials in gene therapy, accelerating approval for medicinal products and more.

Regulatory agencies from around the world will be represented among session speakers and panelists. Agencies participating include: the US Food and Drug Administration (FDA); the European Medicines Agency (EMA); the World Health Organization (WHO); the Pan American Health Organization (PAHO); the Health Surveillance Agency, Brazil (ANVISA); the Pharmaceuticals and Medical Devices Agency, Japan (PMDA); the Medicines and Healthcare products Regulatory Agency, UK (MHRA); the National Regulatory Authority, Cuba and others.

For the full conference schedule, visit http://www.raps.org/convergence/#agenda Follow conference updates and conversations on Twitter using the #2017RAPS hashtag. Today, 10 August, is the final day for early discounted registration but attendees may register any time, including on site.

Reporters, bloggers and other members of the media who wish to cover all or part of the RAPS Regulatory Convergence should contact Zachary Brousseau, senior manager, communications, RAPS, at [email protected] or +1 301 770 2920, ext. 245. On-site registration also will be available for media with valid press credentials or a letter from an assigning editor.

About RAPS

The Regulatory Affairs Professionals Society (RAPS) is the largest global organization of and for those involved with the regulation of healthcare and related products, including medical devices, pharmaceuticals, biologics and nutritional products. Founded in 1976, RAPS helped establish the regulatory profession and continues to actively support the professional and lead the profession as a neutral, non-lobbying nonprofit organization. RAPS offers education and training, professional standards, publications, research, knowledge sharing, networking, career development opportunities and other valuable resources, including Regulatory Affairs Certification (RAC), the only post-academic professional credential to recognize regulatory excellence. RAPS is headquartered in suburban Washington, DC, with chapters and affiliates worldwide. RAPS.org

###

Attachments:

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/9de93af6-f8b0-4cf2-a3d9-502756b9f0bb

Zachary Brousseau
Regulatory Affairs Professionals Society (RAPS)
301 770 2920, ext. 245
[email protected]